Priti Patel - Net Worth and Insider Trading

Priti Patel Net Worth

The estimated net worth of Priti Patel is at least $6,512 dollars as of 2024-12-01. Priti Patel is the Former Chief Medical Officer of Neoleukin Therapeutics Inc and owns about 1,866 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $6,512. Details can be seen in Priti Patel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Priti Patel has not made any transactions after 2023-04-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Priti Patel

To

Priti Patel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Priti Patel owns 1 companies in total, including Neoleukin Therapeutics Inc (NLTX) .

Click here to see the complete history of Priti Patel’s form 4 insider trades.

Insider Ownership Summary of Priti Patel

Ticker Comapny Transaction Date Type of Owner
NLTX Neoleukin Therapeutics Inc 2023-04-03 Chief Medical Officer

Priti Patel Latest Holdings Summary

Priti Patel currently owns a total of 1 stock. Priti Patel owns 1,866 shares of Neoleukin Therapeutics Inc (NLTX) as of April 3, 2023, with a value of $6,512.

Latest Holdings of Priti Patel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NLTX Neoleukin Therapeutics Inc 2023-04-03 1,866 3.49 6,512

Holding Weightings of Priti Patel


Priti Patel Form 4 Trading Tracker

According to the SEC Form 4 filings, Priti Patel has made a total of 3 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 188 shares on April 3, 2023, which brought Priti Patel around $2,601.

Insider Trading History of Priti Patel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Priti Patel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Priti Patel Ownership Network

Ownership Network List of Priti Patel

No Data

Ownership Network Relation of Priti Patel

Insider Network Chart

Priti Patel Owned Company Details

What does Neoleukin Therapeutics Inc do?

Who are the key executives at Neoleukin Therapeutics Inc?

Priti Patel is the Chief Medical Officer of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and General Counsel & SVP Legal Donna Cochener .

Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary

Over the past 18 months, Priti Patel made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neoleukin Therapeutics Inc Insider Transactions

No Available Data

Priti Patel Mailing Address

Above is the net worth, insider trading, and ownership report for Priti Patel. You might contact Priti Patel via mailing address: C/o Neoleukin Therapeutics, Inc., 188 East Blaine Street, #450, Seattle Wa 98102.

Discussions on Priti Patel

No discussions yet.